UpTrials, a company addressing clinical research understaffing through their proprietary hiring platform, announced that they have entered into a partnership with Innovo Research, a provider-sponsored, provider-led network of high-performing Accountable Care Organizations (ACOs) that utilize clinical research as part of their population health strategy.

“We’re honored to have Innovo Research as a partner,” said UpTrials CEO Renuka Agarwal. “Innovo Research is dedicated to innovating in clinical research and providing a seamless experience for patients. They understand the value in providing early feedback to us, and we’re excited to work with them.”

UpTrials is an online hiring platform that enables clinical research employers like Innovo Research to quickly access prescreened clinical research professionals and identify relevant candidates for hire based on clinical research skills and therapeutic area experience. UpTrials algorithmically matches employers with candidates, and provides employers with valuable hiring data. Through this partnership, Innovo Research will be able to accelerate and optimize clinical research hiring across the multiple clinical research locations they operate in Connecticut, Florida, Illinois, Kansas, North Carolina, Texas and Washington.

“UpTrials provides a fantastic service, and I haven’t seen anything like it,” said Innovo Research COO Cerdi Beltre. “UpTrials will save us a lot of time in hiring across our sites, and we’re excited to use the platform.”

About UpTrials UpTrials is an innovative clinical research company dedicated to addressing clinical research understaffing through their proprietary hiring platform. UpTrials enables clinical research employers, including sites, CROs and sponsors, to quickly hire the most relevant talent for their clinical trial needs, improving trial timelines and success. UpTrials enables clinical research professionals to discover roles that best fit their profiles, improving retention and professional development.

About Innovo Research Innovo Research is dedicated to promoting clinical research as a patient care option by demonstrating its value to all stakeholders in improving healthcare outcomes for patients, reducing the cost of healthcare to patients, and improving patient engagement and satisfaction with their healthcare experience. In addition to their research network and support services, Innovo Research also supports the pharma industry by assisting with the pragmatic design of future trials and observational study capabilities once their therapeutic is in the market.

Austin Regional Clinic (ARC), a leading multispecialty medical group serving the Central Texas community since 1980, has proudly announced its partnership with Innovo Research, a provider-sponsored, provider-led network of high-performing medical organizations focused on innovative clinical research strategies.

By joining forces with Innovo Research, ARC aims to enhance its commitment to providing Central Texas with access to advanced medical treatment by integrating cutting-edge research methodologies into patient care. ARC first opened its clinical research department at the end of 2016 and was a major study center for COVID-19 vaccines in 2020 and 2021. This partnership enables ARC to collaborate with a network of like-minded organizations and continue to play a role in advancing science and medicine, while benefiting individuals in local communities.

Anas Daghestani, MD, ARC President & CEO, expressed enthusiasm about this collaboration, stating, “We believe that by combining our decades of expertise in patient care with the experience of Innovo Research in innovative and rigorous clinical research, we can continue to enhance ARC’s healthcare model that truly prioritizes patient outcomes and community well-being.”

Jeff James, CEO of Innovo Research, echoed this sentiment, saying, “We are thrilled to welcome Austin Regional Clinic into the Innovo family. Their dedication to patient-centric and high-quality care aligns perfectly with our mission, and we are confident that together, we will advance these goals.”

The partnership signifies a meaningful next step in the evolution of health care, where research and patient care converge to create a more efficient, accessible, and patient-focused approach. For more information about this collaboration and the services offered by ARC and Innovo Research, please visit ARC Clinical Research and Innovo Research.

Innovo Research announced today the appointment of Halley Losekamp as senior vice president of corporate strategy and partnerships at the company. Losekamp, a clinical research and healthcare industry veteran, joins the company after serving in a similar capacity at BEKHealth based in New York.

“We couldn’t be happier to have Halley join the Innovo Research team,” said Jeff James, Innovo Research chief executive officer. “We’ve proven that our value-based clinical research structure works well for our site partners and study sponsors. Now was the time to find the right person to share our strategy with more organizations looking to change the way that clinical research is viewed and implemented within healthcare systems. We were impressed with Halley’s experience and capabilities and have no doubt that she will positively impact the future of Innovo Research.”

As senior vice president of corporate strategy and partnerships at Innovo Research, Losekamp will be responsible for a wide range of activities, including:

• Designing and executing growth strategies responsive to partner site interests, strategic priorities, and population health targets
• Establishing a cohesive go-to-market strategy and ensure its alignment with the company’s overall strategic plan
• Spearheading revenue growth through the acquisition of new studies from pharmaceutical sponsors, Contract Research Organizations (CROs), and strategic partners

“Innovo Research is an agile and dynamic organization that is truly reshaping the clinical research landscape within the healthcare industry,” stated Losekamp. “Showing how clinical research as a care option for patients and moving it into the community is something that I look forward to doing. This movement will simultaneously and safely increase the speed to market for important therapies, drive down healthcare costs, and create greater value for patients and providers. It’s an exciting time to be in the clinical research space and work with such a forward-thinking team at Innovo Research.”

About Innovo Research – Innovo Research is a provider-sponsored, provider-led network of high-performing Accountable Care Organizations (ACOs) that utilize clinical research as part of their population health strategy. Our integrated approach supports both the triple aim aspirations of our partner ACOs as well as their research interests. Our fully integrated EMR platform allows for quick and reliable feasibility analysis, leading to quicker enrollment. Our depth and breadth of investigators cover nearly every therapeutic area across several geographic regions.

Population health approaches play a vital role in improving overall health within communities. By focusing on specific population needs, these initiatives strive to enhance healthcare outcomes through preventive measures, early detection, and coordinated care. Integrating research into population health strategies allows for evidence-based interventions, outcome evaluation, and continuous improvement. This integration can serve as a model for how research can support clinical practices in meeting patient care needs for better outcomes.

CONCLUSION: Using CRIO’s integrated eConsent-eSource solution, Innovo Research has a tool they can deploy to improve enrollment significantly, while protecting patient safety and ensuring data quality at point of capture. This helps Innovo Research deliver significant value to pharmaceutical and device sponsors and their partner health systems at the same time, helping them achieve the vision of integrating research into care delivery and population health management.